The Second Ever FDA Approved Drug for Cholangiocarcinoma (CCA)
As reported in Fierce Pharma; BridgeBio has earned FDA approval for their new targeted cancer treatment, Truseltiq. The approval is the biotech company’s first ever approval for a cancer drug,…